| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Kozarich John W is a Director at LGNYZ, with reported holdings spanning 3 companies. Recent filings cover 0 purchases and 80 sales. Those positions are worth an estimated $2.9M at current prices.
Our model assigns Kozarich John W a middling insider score of 55/100, based on 10 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -19.2%.
Kozarich John W's largest disclosed position is in LGND as Director, worth about $2.9M. The recent filings there lean toward selling, a net 50,230 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2025 | LGND Ligand Pharmaceuticals Inc | Director | Sell10b5-1 | 934 | $125.00 | $116,750.00 | -2.0% | +47.6% | - | |
| May 16, 2023 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 4,444 | $77.20 | $343,080.80 | -10.4% | -13.0% | +11.2% | |
| May 8, 2023 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 6,408 | $76.56 | $490,627.88 | -13.2% | -14.4% | -5.5% | |
| Feb 28, 2022 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 908 | $102.62 | $93,178.96 | -2.2% | -12.2% | -28.7% | |
| May 14, 2019 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 2,500 | $112.92 | $282,300.00 | -8.9% | - | - | |
| Oct 1, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 2,500 | $275.04 | $687,610.00 | -8.7% | - | - | |
| Jul 2, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 2,500 | $207.48 | $518,699.25 | -8.0% | - | - | |
| Apr 2, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 2,500 | $160.43 | $401,062.50 | -7.5% | - | - | |
| Jan 10, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 2,500 | $145.00 | $362,500.00 | -7.0% | - | - | |
| Nov 16, 2017 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 5,000 | $141.71 | $708,550.00 | -12.3% | - | - |